PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
16142439-0	2005	Nordihydroguaiaretic acid (NDGA) inhibits the IGF-1 and c-erbB2/HER2/neu receptors and suppresses growth in breast cancer cells.	Masoprocol	0-25	erb-b2 receptor tyrosine kinase 2	Homo sapiens	56-63	
18645000-0	2008	Nordihydroguaiaretic acid, a cytotoxic insulin-like growth factor-I receptor/HER2 inhibitor in trastuzumab-resistant breast cancer.	Masoprocol	0-25	erb-b2 receptor tyrosine kinase 2	Homo sapiens	77-81	
18645000-3	2008	In the current study, we show that the phenolic compound nordihydroguaiaretic acid (NDGA) promoted cell death of trastuzumab-naive and trastuzumab-refractory HER2-overexpressing breast cancer cells.	Masoprocol	57-82	erb-b2 receptor tyrosine kinase 2	Homo sapiens	158-162	
18645000-3	2008	In the current study, we show that the phenolic compound nordihydroguaiaretic acid (NDGA) promoted cell death of trastuzumab-naive and trastuzumab-refractory HER2-overexpressing breast cancer cells.	Masoprocol	84-88	erb-b2 receptor tyrosine kinase 2	Homo sapiens	158-162	
17562544-0	2008	Nordihydroguaiaretic acid (NDGA), an inhibitor of the HER2 and IGF-1 receptor tyrosine kinases, blocks the growth of HER2-overexpressing human breast cancer cells.	Masoprocol	0-25	erb-b2 receptor tyrosine kinase 2	Homo sapiens	54-58	
17562544-0	2008	Nordihydroguaiaretic acid (NDGA), an inhibitor of the HER2 and IGF-1 receptor tyrosine kinases, blocks the growth of HER2-overexpressing human breast cancer cells.	Masoprocol	0-25	erb-b2 receptor tyrosine kinase 2	Homo sapiens	117-121	
17562544-0	2008	Nordihydroguaiaretic acid (NDGA), an inhibitor of the HER2 and IGF-1 receptor tyrosine kinases, blocks the growth of HER2-overexpressing human breast cancer cells.	Masoprocol	27-31	erb-b2 receptor tyrosine kinase 2	Homo sapiens	54-58	
17562544-0	2008	Nordihydroguaiaretic acid (NDGA), an inhibitor of the HER2 and IGF-1 receptor tyrosine kinases, blocks the growth of HER2-overexpressing human breast cancer cells.	Masoprocol	27-31	erb-b2 receptor tyrosine kinase 2	Homo sapiens	117-121	
17562544-1	2008	We have reported that nordihydroguaiaretic acid (NDGA) inhibits the tyrosine kinase activities of the IGF-1 receptor (IGF-1R) and the HER2 receptor in breast cancer cells.	Masoprocol	22-47	erb-b2 receptor tyrosine kinase 2	Homo sapiens	134-138	
17562544-1	2008	We have reported that nordihydroguaiaretic acid (NDGA) inhibits the tyrosine kinase activities of the IGF-1 receptor (IGF-1R) and the HER2 receptor in breast cancer cells.	Masoprocol	49-53	erb-b2 receptor tyrosine kinase 2	Homo sapiens	134-138	
16142439-0	2005	Nordihydroguaiaretic acid (NDGA) inhibits the IGF-1 and c-erbB2/HER2/neu receptors and suppresses growth in breast cancer cells.	Masoprocol	0-25	erb-b2 receptor tyrosine kinase 2	Homo sapiens	64-72	
16142439-0	2005	Nordihydroguaiaretic acid (NDGA) inhibits the IGF-1 and c-erbB2/HER2/neu receptors and suppresses growth in breast cancer cells.	Masoprocol	27-31	erb-b2 receptor tyrosine kinase 2	Homo sapiens	56-63	
16142439-0	2005	Nordihydroguaiaretic acid (NDGA) inhibits the IGF-1 and c-erbB2/HER2/neu receptors and suppresses growth in breast cancer cells.	Masoprocol	27-31	erb-b2 receptor tyrosine kinase 2	Homo sapiens	64-72	
16142439-6	2005	NDGA was also effective at inhibiting autophosphorylation of the isolated HER2/neu receptor at similar concentrations.	Masoprocol	0-4	erb-b2 receptor tyrosine kinase 2	Homo sapiens	74-82